Ulthera, which makes an ultrasound device designed to lift lax tissue on the neck and under the chin, registers for an initial public offering worth up to $86 million.
Ulthera filed for a U.S. initial public offering yesterday, saying it hopes to raise as much as $86 million when it debuts on the NASDAQ stock exchange.
Mesa, Ariz.-based Ulthera makes an ultrasound device, which is designed to use the body's natural healing process to non-invasively lift and tighten loose skin on the neck and under the chin.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hkBrDb
Cap comentari:
Publica un comentari a l'entrada